Please use this identifier to cite or link to this item:
Title: Anti-Mycobacterium abscessus activity of tuberculosis F-ATP synthase inhibitor GaMF1
Authors: Ragunathan, Priya
Dick, Thomas
Grüber, Gerhard
Keywords: Science::Chemistry::Biochemistry
Issue Date: 2022
Source: Ragunathan, P., Dick, T. & Grüber, G. (2022). Anti-Mycobacterium abscessus activity of tuberculosis F-ATP synthase inhibitor GaMF1. Antimicrobial Agents and Chemotherapy, 66(5), e00018-22-.
Project: NRF–CRP18–2017–01
Journal: Antimicrobial Agents and Chemotherapy 
Abstract: New drug targets and molecules with bactericidal activity are needed against the respiratory mycobacterial pathogen Mycobacterium abscessus (Mab). Employing a lead repurposing strategy, the anti-tuberculosis compound GaMF1 was tested against Mab. Whole cell- and ATP synthesis assays demonstrated that GaMF1 inhibits growth and kills Mab by targeting the F-ATP synthase. GaMF1’s anti-Mab activity increased in combination with clofazimine, rifabutin or amikacin The study expands the repertoire of anti-Mab compounds targeting oxidative phosphorylation.
ISSN: 0066-4804
DOI: 10.1128/aac.00018-22
Schools: School of Biological Sciences 
Rights: © 2022 American Society for Microbiology. All Rights Reserved. This paper was published in Antimicrobial Agents and Chemotherapy and is made available with permission of American Society for Microbiology.
Fulltext Permission: open
Fulltext Availability: With Fulltext
Appears in Collections:SBS Journal Articles

Files in This Item:
File Description SizeFormat 
AAC00018-22R1_Merged_PDF.pdf1.1 MBAdobe PDFThumbnail

Citations 50

Updated on Apr 8, 2024

Web of ScienceTM
Citations 50

Updated on Oct 24, 2023

Page view(s)

Updated on Apr 18, 2024

Download(s) 50

Updated on Apr 18, 2024

Google ScholarTM




Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.